![David Rabuka](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Rabuka
Chief Executive Officer at Acrigen Biosciences, Inc.
Profile
David Rabuka was the founder of Redwood Bioscience, Inc. (founded in 2008) and Acrigen Biosciences, Inc. (founded in 2019), where he held the titles of Chief Scientific Officer and President & Chief Executive Officer, respectively.
He also worked as a Staff Scientist at Optimer Pharmaceuticals LLC.
Dr. Rabuka received his graduate degree from the University of Alberta, his undergraduate degree from the University of Saskatchewan, and his doctorate from the University of California, Berkeley.
David Rabuka active positions
Companies | Position | Start |
---|---|---|
Acrigen Biosciences, Inc.
![]() Acrigen Biosciences, Inc. BiotechnologyHealth Technology Acrigen Biosciences, Inc. operates as a early-stage life science gene editing company. The company was founded by Joseph Bondy-Denomy in 2019 and is headquartered in Kensington, CA. | Chief Executive Officer | 2018-12-31 |
Former positions of David Rabuka
Companies | Position | End |
---|---|---|
Optimer Pharmaceuticals LLC
![]() Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Corporate Officer/Principal | - |
Redwood Bioscience, Inc.
![]() Redwood Bioscience, Inc. BiotechnologyHealth Technology Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA. | Founder | - |
Training of David Rabuka
University of California, Berkeley | Doctorate Degree |
University of Alberta | Graduate Degree |
University of Saskatchewan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Redwood Bioscience, Inc.
![]() Redwood Bioscience, Inc. BiotechnologyHealth Technology Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA. | Health Technology |
Optimer Pharmaceuticals LLC
![]() Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
Acrigen Biosciences, Inc.
![]() Acrigen Biosciences, Inc. BiotechnologyHealth Technology Acrigen Biosciences, Inc. operates as a early-stage life science gene editing company. The company was founded by Joseph Bondy-Denomy in 2019 and is headquartered in Kensington, CA. | Health Technology |
- Stock Market
- Insiders
- David Rabuka